The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
Clinical trial NCT07080775 · RECRUITING
Trial details
- NCT number
- NCT07080775
- Sponsor
- XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2026-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.